Value of combined androgen blockade in the neoadjuvant treatment of localized prostate cancer: the jury must remain out

J Clin Oncol. 2010 Sep 1;28(25):e445-6; author reply e447. doi: 10.1200/JCO.2010.29.4868. Epub 2010 Jul 6.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Androgen Antagonists / administration & dosage*
  • Clinical Trials as Topic
  • Flutamide / administration & dosage*
  • Gonadotropin-Releasing Hormone / antagonists & inhibitors*
  • Humans
  • Male
  • Neoadjuvant Therapy
  • Prostatic Neoplasms / drug therapy*
  • Time Factors

Substances

  • Androgen Antagonists
  • Gonadotropin-Releasing Hormone
  • Flutamide